Francesco Maria Lavino, Chief Commercial Officer at Nabriva Therapeutics plc (NBRV), bought 4,800 shares at $2.04 ($10K) on 2019-08-22, disclosed to the SEC on 2019-08-26.
Open-market purchase of $10k NBRV by Chief Commercial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |